ATP7A and breast cancer: To explore the cisplatin‐sensitivity of breast cancer cells knocked‐down ATP7A by siRNA, first, MDA‐MB‐231 cells were transfected with si‐ATP7A to achieve ATP7A knockdown, as verified using western blot (Figure 2A).